Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics

Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related facto...

Full description

Bibliographic Details
Main Authors: Shannon Palmer, Ashley Chen, Taylor Dennison, Cameron Czech, Jessica Auten, Kaitlyn Buhlinger, Benyam Muluneh
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmacy
Subjects:
Online Access:https://www.mdpi.com/2226-4787/9/3/130
_version_ 1797517543578009600
author Shannon Palmer
Ashley Chen
Taylor Dennison
Cameron Czech
Jessica Auten
Kaitlyn Buhlinger
Benyam Muluneh
author_facet Shannon Palmer
Ashley Chen
Taylor Dennison
Cameron Czech
Jessica Auten
Kaitlyn Buhlinger
Benyam Muluneh
author_sort Shannon Palmer
collection DOAJ
description Oncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients’ ownership of their care. This narrative review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians.
first_indexed 2024-03-10T07:18:00Z
format Article
id doaj.art-125320b66771429f9e2468e824a4d0dd
institution Directory Open Access Journal
issn 2226-4787
language English
last_indexed 2024-03-10T07:18:00Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Pharmacy
spelling doaj.art-125320b66771429f9e2468e824a4d0dd2023-11-22T14:49:15ZengMDPI AGPharmacy2226-47872021-07-019313010.3390/pharmacy9030130Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral OncolyticsShannon Palmer0Ashley Chen1Taylor Dennison2Cameron Czech3Jessica Auten4Kaitlyn Buhlinger5Benyam Muluneh6Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USADepartment of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC 27514, USAUNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27514, USAOncology clinical pharmacists are uniquely positioned to make interventions to impact the knowledge, attitudes, and practices of clinicians as well as patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients’ ownership of their care. This narrative review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians.https://www.mdpi.com/2226-4787/9/3/130patient activationpatient engagementbehavioral health changeself-administered therapyoral oncolytic
spellingShingle Shannon Palmer
Ashley Chen
Taylor Dennison
Cameron Czech
Jessica Auten
Kaitlyn Buhlinger
Benyam Muluneh
Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
Pharmacy
patient activation
patient engagement
behavioral health change
self-administered therapy
oral oncolytic
title Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
title_full Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
title_fullStr Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
title_full_unstemmed Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
title_short Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics
title_sort impact of oncology pharmacists on the knowledge attitude and practices of clinicians to enhance patient engagement of self administered oral oncolytics
topic patient activation
patient engagement
behavioral health change
self-administered therapy
oral oncolytic
url https://www.mdpi.com/2226-4787/9/3/130
work_keys_str_mv AT shannonpalmer impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT ashleychen impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT taylordennison impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT cameronczech impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT jessicaauten impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT kaitlynbuhlinger impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics
AT benyammuluneh impactofoncologypharmacistsontheknowledgeattitudeandpracticesofclinicianstoenhancepatientengagementofselfadministeredoraloncolytics